AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
25 nov. 2024 16h02 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care...
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
12 nov. 2024 16h03 HE
|
AVITA Medical
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
AVITA Medical to Host Investor Webinar Briefing
08 nov. 2024 09h00 HE
|
AVITA Medical
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on November 12, 2024.
AVITA Medical Reports Third Quarter Financial Results
07 nov. 2024 16h03 HE
|
AVITA Medical
AVITA Medical reported third-quarter commercial revenue of $19.5 million, reflecting an approximately 44% increase over the same period last year.
AVITA Medical to Announce Third Quarter 2024 Financial Results
10 oct. 2024 17h15 HE
|
AVITA Medical
AVITA Medical announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on November 7, 2024.
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
12 sept. 2024 16h05 HE
|
AVITA Medical
AVITA Medical to present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 9:10 a.m. Eastern Time.
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
10 sept. 2024 16h03 HE
|
AVITA Medical
AVITA Medical will participate in Lake Street Capital Markets’ 8th Annual Best Ideas Growth (BIG8) Conference in New York on September 12, 2024.
AVITA Medical to Host Investor Webinar Briefing
08 août 2024 19h00 HE
|
AVITA Medical
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on August 13, 2024.
AVITA Medical Reports Second Quarter Financial Results
08 août 2024 16h04 HE
|
AVITA Medical
AVITA Medical today reported second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year.
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
01 août 2024 16h05 HE
|
AVITA Medical
AVITA Medical announces industry leader, Robin VanDenburgh, has joined as Senior Vice President of U.S. Commercial Sales, effective August 6, 2024.